Plus Therapeutics Highlights Updates On Lead Program In Brain Cancer Indications
November 21, 2022 at 06:53 AM EST
Plus Therapeutics Inc(NASDAQ: PSTV)presented datafrom two ongoing trials evaluating its lead investigational ...
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.